PERRIGO COMPANY PLC PRGO
Analyst Ratings
- Consensus
- Hold — 1 Buy · 2 Hold · 0 Sell (3 analysts)
- Avg. Price Target
- $19.33 (+42.6% upside)
Key Stats
- Today's Range
- $13.15 – $13.67
- 50-Day Range
- $9.81 – $14.99
- 52-Week Range
- $9.22 – $24.61
- Volume
- 6.88 million shs
- Average Volume
- 2.55 million shs
- Market Cap
- $1.88 billion
- P/E Ratio
- —
- Dividend Yield
- 8.55%
Valuation
- P/E Ratio
- —
- Price / Book
- 0.75
- Price / Sales
- 0.45
Dividend
- Dividend Yield
- 8.55%
- Annual Dividend
- $1.16
- Payout Ratio
- —
- Ex-Dividend Date
- 2026-08-28
Short Interest
- Short Interest
- 2.42%
- Days to Cover
- 4.42
Financials (TTM)
- Revenue
- $4.14 billion
- Net Income
- $-1,734,800,000
- Net Margin
- -41.85%
- Return on Equity
- -68.96%
- Debt-to-Equity
- —
About PERRIGO COMPANY PLC
Perrigo is a pure-play consumer healthcare product manufacturer and distributor. In North America (two-thirds of total sales), the firm's product mix is anchored in private-label consumer health goods, which are sold to major retailers like Walmart, Amazon, Costco, and CVS. It plays in a number of over-the-counter categories including pain, skincare, women's health, and nutrition. Perrigo also competes in Europe, Australia, and parts of Asia, where it primarily generates revenue through its national brands, including Compeed, Solpadeine, Coldrex, and ellaOne.
Related Stocks
Compare head-to-head: PRGO vs LLY·PRGO vs JNJ·PRGO vs ABBV·PRGO vs ABT
Price and fundamental data are delayed and provided for informational purposes only. Not investment advice. See our disclaimer.